SOP Epileptische Anfälle auf der Intensivstation

In dieser Rubrik stellen wir Standard Operating Procedures (SOPs) für perioperativ und intensivmedizinisch relevante Prozesse vor. Die Form ist eher im Sinne einer Schablone zu verstehen als – durchaus subjektiv gefärbte – Anregung, eigene, auf lokale Gegebenheiten adaptierte stationsinterne SOPs zu entwerfen und zu implementieren.

• Literatur

• 1 Fisher RS, Acevedo C, Arzimanoglou A. et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014; 55: 475-482
• 2 Beghi E, Carpio A, Forsgren L. et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia 2010; 51: 671-675
• 3 Hesdorffer DC, Benn EK, Cascino GD. et al. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia 2009; 50: 1102-1108
• 4 Fisher RS, Cross JH, French JA. et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58: 522-530
• 5 Pottkämper JCM, Hofmeijer J, van Waarde JA. et al. The postictal state – What do we know?. Epilepsia 2020; 61: 1045-1061
• 6 Trinka E, Cock H, Hesdorffer D, Rossetti AO. et al. A definition and classification of status epilepticus –Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 2015; 56: 1515-1523
• 7 Rosenow F, Weber J. et al. Status epilepticus im Erwachsenenalter. S2k-Leitlinie. 2020. In: Deutsche Gesellschaft für Neurologie, Hrsg. Accessed September 29, 2022 at: https://www.dgn.org/leitlinien
• 8 Jungilligens J, Michaelis R, Popkirov S. Misdiagnosis of prolonged psychogenic non-epileptic seizures as status epilepticus: epidemiology and associated risks. JNNP 2021; 92: 1341-1345
• 9 Vorderwülbecke BJ, Lichtner G, von Dincklage F. et al. Acute antiepileptic drug use in intensive care units. J Neurol 2018; 265: 2841-2850
• 10 Betjemann JP, Lowenstein DH. Status epilepticus in adults. Lancet Neurol 2015; 14: 615-624
• 11 Hesdorffer DC, Benn EK, Cascino GD. et al. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia 2009; 50: 1102-1108
• 12 Rosenow F, Alonso-Vanegas MA, Baumgartner C. Surgical Task Force, Commission on Therapeutic Strategies of the ILAE. et al. Cavernoma-related epilepsy: review and recommendations for management – report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2013; 54: 2025-2035
• 13 Sanghan N, Lin S, Tartrakoon G. et al. Factors associated with acute symptomatic seizure occurrence among patients with posterior reversible encephalopathy syndrome. Epilepsy Behav 2022; 134: 108834
• 14 Leung H, Man CB, Hui AC. et al. Prognosticating acute symptomatic seizures using two different seizure outcomes. Epilepsia 2010; 51: 1570-1579
• 15 Elger CE, Berkenfeld R. et al. S1-Leitlinie Erster epileptischer Anfall und Epilepsien im Erwachsenenalter. 2017. In: Deutsche Gesellschaft für Neurologie, Hrsg. Accessed September 29, 2022 at: https://www.dgn.org/leitlinien
• 16 Holtkamp M, Beghi E, Benninger F. et al. European Stroke Organisation guidelines for the management of post-stroke seizures and epilepsy. Eur Stroke J 2017; 2: 103-115
• 17 Punia V, Honomichl R, Chandan P. et al. Long-term continuation of anti-seizure medications after acute stroke. Ann Clin Transl Neurol 2021; 8: 1857-1866
• 18 Hesdorffer DC, Logroscino G, Cascino G. et al. Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann Neurol 1998; 44: 908-912
• 19 Galovic M, Döhler N, Erdelyi-Canavese B. et al. Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation study. Lancet Neurol 2018; 17: 143-152
• 20 Löscher W, Klein P. The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond. CNS Drugs 2021; 35: 935-963